Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

Sep 21, 2023

BUY
$153.94 - $174.85 $4.37 Million - $4.97 Million
28,400 Added 171.08%
45,000 $7.53 Million
Q1 2021

May 14, 2021

BUY
$153.94 - $174.85 $4.37 Million - $4.97 Million
28,400 Added 171.08%
45,000 $7.53 Million
Q4 2020

Sep 21, 2023

BUY
$101.87 - $151.79 $1.69 Million - $2.52 Million
16,600 New
16,600 $2.52 Million
Q4 2020

Feb 16, 2021

BUY
$101.87 - $151.79 $1.69 Million - $2.52 Million
16,600 New
16,600 $2.52 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.